Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 14 | 2021 | 471 | 3.640 |
Why?
|
| Insulin Resistance | 5 | 2021 | 241 | 2.490 |
Why?
|
| Leptin | 6 | 2021 | 80 | 2.340 |
Why?
|
| Neuronal Plasticity | 6 | 2019 | 274 | 2.020 |
Why?
|
| Insulin | 9 | 2021 | 617 | 1.760 |
Why?
|
| Stress, Psychological | 8 | 2018 | 824 | 1.490 |
Why?
|
| Receptor, Insulin | 7 | 2020 | 71 | 1.460 |
Why?
|
| Amygdala | 6 | 2012 | 159 | 1.250 |
Why?
|
| Mental Disorders | 3 | 2021 | 659 | 1.070 |
Why?
|
| Citalopram | 2 | 2021 | 29 | 1.000 |
Why?
|
| Aging | 4 | 2017 | 911 | 0.960 |
Why?
|
| Cognitive Dysfunction | 3 | 2021 | 176 | 0.950 |
Why?
|
| Food Deprivation | 2 | 2014 | 22 | 0.870 |
Why?
|
| Obesity | 4 | 2021 | 1074 | 0.860 |
Why?
|
| Animals | 28 | 2022 | 20877 | 0.810 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 37 | 0.800 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 81 | 0.780 |
Why?
|
| Thiazepines | 3 | 2012 | 14 | 0.770 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2018 | 2083 | 0.760 |
Why?
|
| Glutamic Acid | 3 | 2012 | 332 | 0.750 |
Why?
|
| Stress, Physiological | 3 | 2012 | 215 | 0.740 |
Why?
|
| Brain Chemistry | 1 | 2020 | 173 | 0.700 |
Why?
|
| Rats | 14 | 2021 | 5300 | 0.690 |
Why?
|
| Antidepressive Agents | 3 | 2021 | 216 | 0.630 |
Why?
|
| Histamine | 3 | 2022 | 52 | 0.620 |
Why?
|
| Hypothalamus | 3 | 2014 | 78 | 0.600 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 438 | 0.580 |
Why?
|
| Spatial Learning | 1 | 2015 | 12 | 0.540 |
Why?
|
| Diabetes Mellitus | 4 | 2011 | 693 | 0.530 |
Why?
|
| Chronic Disease | 2 | 2017 | 1329 | 0.500 |
Why?
|
| Anhedonia | 1 | 2014 | 15 | 0.480 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2012 | 45 | 0.470 |
Why?
|
| Appetite Regulation | 1 | 2013 | 11 | 0.450 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2012 | 208 | 0.440 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.440 |
Why?
|
| Down-Regulation | 2 | 2011 | 447 | 0.440 |
Why?
|
| Acetamides | 1 | 2012 | 17 | 0.430 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 563 | 0.430 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 639 | 0.420 |
Why?
|
| Signal Transduction | 4 | 2017 | 2688 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 290 | 0.400 |
Why?
|
| Serotonin | 2 | 2022 | 144 | 0.400 |
Why?
|
| Corticosterone | 2 | 2010 | 51 | 0.390 |
Why?
|
| Depression | 3 | 2021 | 942 | 0.380 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 57 | 0.380 |
Why?
|
| Brain | 3 | 2011 | 2175 | 0.380 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 53 | 0.380 |
Why?
|
| Peptides | 1 | 2013 | 455 | 0.360 |
Why?
|
| Cognition Disorders | 2 | 2011 | 342 | 0.340 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 1293 | 0.330 |
Why?
|
| Neurons | 3 | 2011 | 881 | 0.330 |
Why?
|
| Membrane Proteins | 1 | 2012 | 617 | 0.320 |
Why?
|
| Disease Models, Animal | 6 | 2012 | 2550 | 0.320 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2007 | 34 | 0.300 |
Why?
|
| Humans | 15 | 2021 | 68525 | 0.300 |
Why?
|
| Neuropeptides | 2 | 2021 | 106 | 0.290 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2006 | 26 | 0.290 |
Why?
|
| Male | 17 | 2022 | 37281 | 0.290 |
Why?
|
| Affect | 1 | 2007 | 218 | 0.280 |
Why?
|
| Memory | 1 | 2007 | 214 | 0.280 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 1506 | 0.270 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 124 | 0.270 |
Why?
|
| Body Weight | 3 | 2014 | 554 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 1085 | 0.260 |
Why?
|
| Hydrocortisone | 1 | 2006 | 291 | 0.260 |
Why?
|
| Phosphorylation | 3 | 2015 | 1199 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 529 | 0.240 |
Why?
|
| Cytokines | 2 | 2021 | 866 | 0.230 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 99 | 0.220 |
Why?
|
| Phenotype | 1 | 2005 | 946 | 0.220 |
Why?
|
| Analysis of Variance | 4 | 2012 | 1039 | 0.210 |
Why?
|
| Adiposity | 2 | 2011 | 88 | 0.190 |
Why?
|
| Dominance-Subordination | 1 | 2018 | 11 | 0.160 |
Why?
|
| Orexins | 2 | 2021 | 52 | 0.160 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2018 | 52 | 0.160 |
Why?
|
| Microdialysis | 3 | 2012 | 147 | 0.150 |
Why?
|
| Glucose | 2 | 2008 | 307 | 0.140 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 257 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 244 | 0.130 |
Why?
|
| Depressive Disorder | 2 | 2008 | 621 | 0.120 |
Why?
|
| Eating | 1 | 2014 | 119 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 114 | 0.110 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.110 |
Why?
|
| Restraint, Physical | 3 | 2008 | 59 | 0.110 |
Why?
|
| Synaptic Transmission | 2 | 2012 | 236 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 180 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 266 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 132 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 216 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2011 | 16 | 0.100 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2011 | 10 | 0.100 |
Why?
|
| Electroshock | 1 | 2011 | 36 | 0.100 |
Why?
|
| Food Preferences | 1 | 2011 | 46 | 0.100 |
Why?
|
| Swimming | 1 | 2011 | 38 | 0.100 |
Why?
|
| RNA, Antisense | 1 | 2010 | 25 | 0.100 |
Why?
|
| Autoradiography | 1 | 2010 | 94 | 0.100 |
Why?
|
| Maze Learning | 1 | 2011 | 138 | 0.100 |
Why?
|
| Triglycerides | 1 | 2011 | 184 | 0.100 |
Why?
|
| Serine | 1 | 2010 | 99 | 0.090 |
Why?
|
| Anxiety | 2 | 2018 | 422 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2011 | 311 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.090 |
Why?
|
| Inflammation | 3 | 2022 | 1030 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.090 |
Why?
|
| tau Proteins | 1 | 2008 | 61 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2008 | 102 | 0.080 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2008 | 150 | 0.080 |
Why?
|
| Pituitary-Adrenal System | 1 | 2008 | 138 | 0.080 |
Why?
|
| Limbic System | 1 | 2008 | 106 | 0.080 |
Why?
|
| Adrenalectomy | 1 | 2006 | 17 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.070 |
Why?
|
| Protein Transport | 1 | 2007 | 280 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2005 | 6 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2006 | 246 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2007 | 523 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 2790 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2006 | 222 | 0.060 |
Why?
|
| Female | 4 | 2022 | 38015 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 770 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1663 | 0.050 |
Why?
|
| Orexin Receptors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2021 | 88 | 0.050 |
Why?
|
| Mice | 2 | 2022 | 8472 | 0.040 |
Why?
|
| Sodium Channel Blockers | 2 | 2008 | 23 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2018 | 49 | 0.040 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2018 | 16 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2018 | 46 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 88 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2018 | 79 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2018 | 203 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 1593 | 0.040 |
Why?
|
| Heart Rate | 1 | 2018 | 568 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2008 | 26 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cell Count | 1 | 2008 | 248 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2008 | 77 | 0.020 |
Why?
|
| Fluoxetine | 1 | 2007 | 40 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2007 | 29 | 0.020 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2007 | 53 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2007 | 200 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 139 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 658 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14842 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.020 |
Why?
|